Pfizer Inc. (PFE)
USD 25.89
(-2.04%)
USD 25.89
(-2.04%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.35 Billion USD | -89.42% |
| 2022 | 40.03 Billion USD | 61.2% |
| 2021 | 24.83 Billion USD | 133.61% |
| 2020 | 10.63 Billion USD | -29.77% |
| 2019 | 15.13 Billion USD | 0.61% |
| 2018 | 15.04 Billion USD | 6.65% |
| 2017 | 14.1 Billion USD | 2.75% |
| 2016 | 13.73 Billion USD | 5.81% |
| 2015 | 12.97 Billion USD | -3.87% |
| 2014 | 13.49 Billion USD | -17.52% |
| 2013 | 16.36 Billion USD | -9.03% |
| 2012 | 17.99 Billion USD | -1.01% |
| 2011 | 18.17 Billion USD | 28.37% |
| 2010 | 14.15 Billion USD | -9.54% |
| 2009 | 15.65 Billion USD | 4.1% |
| 2008 | 15.03 Billion USD | 45.45% |
| 2007 | 10.33 Billion USD | -27.63% |
| 2006 | 14.28 Billion USD | -4.31% |
| 2005 | 14.92 Billion USD | -12.33% |
| 2004 | 17.02 Billion USD | 57.63% |
| 2003 | 10.8 Billion USD | -12.04% |
| 2002 | 12.27 Billion USD | 11.86% |
| 2001 | 10.97 Billion USD | 26.6% |
| 2000 | 8.67 Billion USD | 90.59% |
| 1999 | 4.54 Billion USD | 26.26% |
| 1998 | 3.6 Billion USD | 7.68% |
| 1997 | 3.34 Billion USD | 8.64% |
| 1996 | 3.08 Billion USD | 20.3% |
| 1995 | 2.56 Billion USD | 29.79% |
| 1994 | 1.97 Billion USD | 115.98% |
| 1993 | 913.3 Million USD | -36.73% |
| 1992 | 1.44 Billion USD | 15.15% |
| 1991 | 1.25 Billion USD | 18.95% |
| 1990 | 1.05 Billion USD | 8.84% |
| 1989 | 968.2 Million USD | -4.32% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 4.55 Billion USD | 386.19% |
| 2024 Q2 | 1.87 Billion USD | -58.78% |
| 2024 Q3 | 5.28 Billion USD | 181.21% |
| 2023 FY | 4.23 Billion USD | -89.42% |
| 2023 Q1 | 6.38 Billion USD | -0.78% |
| 2023 Q2 | 2.07 Billion USD | -67.44% |
| 2023 Q3 | -3.26 Billion USD | -257.12% |
| 2023 Q4 | -1.59 Billion USD | 51.21% |
| 2022 Q3 | 10.42 Billion USD | -19.46% |
| 2022 Q1 | 10.68 Billion USD | 164.31% |
| 2022 Q2 | 12.94 Billion USD | 21.16% |
| 2022 FY | 40.03 Billion USD | 61.2% |
| 2022 Q4 | 6.43 Billion USD | -38.31% |
| 2021 Q1 | 4.7 Billion USD | 314.7% |
| 2021 Q2 | 5.3 Billion USD | 12.87% |
| 2021 Q4 | 4.04 Billion USD | -37.54% |
| 2021 Q3 | 6.47 Billion USD | 21.97% |
| 2021 FY | 24.83 Billion USD | 133.61% |
| 2020 Q1 | 4.16 Billion USD | 109.97% |
| 2020 Q4 | -2.19 Billion USD | -165.81% |
| 2020 Q3 | 3.32 Billion USD | -3.62% |
| 2020 Q2 | 3.45 Billion USD | -17.15% |
| 2020 FY | 10.63 Billion USD | -29.77% |
| 2019 Q1 | 4.16 Billion USD | 30.77% |
| 2019 FY | 15.13 Billion USD | 0.61% |
| 2019 Q4 | 1.98 Billion USD | -40.26% |
| 2019 Q3 | 3.32 Billion USD | -19.95% |
| 2019 Q2 | 4.15 Billion USD | -0.34% |
| 2018 Q2 | 4.02 Billion USD | 0.7% |
| 2018 Q1 | 3.99 Billion USD | 66.75% |
| 2018 FY | 15.04 Billion USD | 6.65% |
| 2018 Q4 | 3.18 Billion USD | -17.25% |
| 2018 Q3 | 3.84 Billion USD | -4.25% |
| 2017 Q1 | 4.1 Billion USD | 74.54% |
| 2017 Q4 | 2.39 Billion USD | -29.23% |
| 2017 Q3 | 3.38 Billion USD | -10.74% |
| 2017 Q2 | 3.79 Billion USD | -7.72% |
| 2017 FY | 14.1 Billion USD | 2.75% |
| 2016 FY | 13.73 Billion USD | 5.81% |
| 2016 Q4 | 2.35 Billion USD | -33.76% |
| 2016 Q2 | 3.79 Billion USD | -5.93% |
| 2016 Q3 | 3.55 Billion USD | -6.35% |
| 2016 Q1 | 4.03 Billion USD | 78.33% |
| 2015 Q1 | 2.94 Billion USD | 29.42% |
| 2015 Q2 | 3.68 Billion USD | 24.91% |
| 2015 Q3 | 3.93 Billion USD | 7.01% |
| 2015 FY | 12.97 Billion USD | -3.87% |
| 2015 Q4 | 2.26 Billion USD | -42.6% |
| 2014 Q3 | 3.66 Billion USD | -9.13% |
| 2014 Q2 | 4.03 Billion USD | 50.19% |
| 2014 Q1 | 2.68 Billion USD | -27.03% |
| 2014 FY | 13.49 Billion USD | -17.52% |
| 2014 Q4 | 2.27 Billion USD | -37.84% |
| 2013 Q4 | 3.67 Billion USD | -12.78% |
| 2013 Q3 | 4.21 Billion USD | 0.02% |
| 2013 Q2 | 4.21 Billion USD | -0.31% |
| 2013 FY | 16.36 Billion USD | -9.03% |
| 2013 Q1 | 4.22 Billion USD | 14.02% |
| 2012 Q1 | 4.8 Billion USD | 12.32% |
| 2012 Q2 | 5.33 Billion USD | 11.07% |
| 2012 Q3 | 4.25 Billion USD | -20.29% |
| 2012 Q4 | 3.7 Billion USD | -12.83% |
| 2012 FY | 17.99 Billion USD | -1.01% |
| 2011 Q2 | 4.44 Billion USD | 1.9% |
| 2011 FY | 18.17 Billion USD | 28.37% |
| 2011 Q4 | 4.27 Billion USD | -15.82% |
| 2011 Q3 | 5.08 Billion USD | 14.28% |
| 2011 Q1 | 4.36 Billion USD | 85.11% |
| 2010 Q1 | 3.95 Billion USD | 15.52% |
| 2010 FY | 14.15 Billion USD | -9.54% |
| 2010 Q4 | 2.35 Billion USD | 4.01% |
| 2010 Q3 | 2.26 Billion USD | -55.82% |
| 2010 Q2 | 5.13 Billion USD | 29.6% |
| 2009 Q4 | 3.42 Billion USD | -20.74% |
| 2009 Q2 | 3.58 Billion USD | -16.74% |
| 2009 Q1 | 4.3 Billion USD | 5.81% |
| 2009 Q3 | 4.32 Billion USD | 20.78% |
| 2009 FY | 15.65 Billion USD | 4.1% |
| 2008 Q4 | 4.06 Billion USD | 61.21% |
| 2008 Q2 | 2.7 Billion USD | -18.67% |
| 2008 FY | 15.03 Billion USD | 45.45% |
| 2008 Q3 | 2.52 Billion USD | -6.94% |
| 2008 Q1 | 3.33 Billion USD | 29.31% |
| 2007 Q1 | 4.74 Billion USD | 82.75% |
| 2007 Q3 | 831 Million USD | -61.93% |
| 2007 FY | 10.33 Billion USD | -27.63% |
| 2007 Q2 | 2.18 Billion USD | -54.0% |
| 2007 Q4 | 2.57 Billion USD | 209.99% |
| 2006 Q4 | 2.59 Billion USD | -32.84% |
| 2006 Q2 | 3.5 Billion USD | -21.43% |
| 2006 Q1 | 4.46 Billion USD | 22.59% |
| 2006 FY | 14.28 Billion USD | -4.31% |
| 2006 Q3 | 3.86 Billion USD | 10.33% |
| 2005 Q3 | 3.73 Billion USD | 10.25% |
| 2005 Q2 | 3.38 Billion USD | -18.83% |
| 2005 Q1 | 4.16 Billion USD | -11.2% |
| 2005 FY | 14.92 Billion USD | -12.33% |
| 2005 Q4 | 3.63 Billion USD | -2.47% |
| 2004 FY | 17.02 Billion USD | 57.63% |
| 2004 Q4 | 4.69 Billion USD | 6.13% |
| 2004 Q3 | 4.42 Billion USD | 22.38% |
| 2004 Q2 | 3.61 Billion USD | -29.27% |
| 2004 Q1 | 5.11 Billion USD | 82.99% |
| 2003 Q2 | 1.89 Billion USD | -45.88% |
| 2003 Q4 | 2.79 Billion USD | 7.18% |
| 2003 Q3 | 2.6 Billion USD | 37.81% |
| 2003 FY | 10.8 Billion USD | -12.04% |
| 2003 Q1 | 3.49 Billion USD | 5.18% |
| 2002 FY | 12.27 Billion USD | 11.86% |
| 2002 Q3 | 3.19 Billion USD | 24.0% |
| 2002 Q1 | 3.17 Billion USD | 14.98% |
| 2002 Q4 | 3.32 Billion USD | 3.88% |
| 2002 Q2 | 2.57 Billion USD | -18.82% |
| 2001 Q1 | 2.78 Billion USD | 21.38% |
| 2001 Q2 | 2.58 Billion USD | -7.25% |
| 2001 Q4 | 2.76 Billion USD | -2.68% |
| 2001 FY | 10.97 Billion USD | 26.6% |
| 2001 Q3 | 2.83 Billion USD | 9.78% |
| 2000 Q2 | 1.66 Billion USD | 14.97% |
| 2000 FY | 8.67 Billion USD | 90.59% |
| 2000 Q4 | 2.29 Billion USD | 0.39% |
| 2000 Q3 | 2.28 Billion USD | 37.25% |
| 2000 Q1 | 1.45 Billion USD | 11.03% |
| 1999 Q1 | 1.15 Billion USD | 45.23% |
| 1999 Q3 | 1.01 Billion USD | -5.04% |
| 1999 FY | 4.54 Billion USD | 26.26% |
| 1999 Q2 | 1.07 Billion USD | -7.35% |
| 1999 Q4 | 1.3 Billion USD | 28.42% |
| 1998 Q1 | 957 Million USD | 14.61% |
| 1998 FY | 3.6 Billion USD | 7.68% |
| 1998 Q2 | 973 Million USD | 1.67% |
| 1998 Q3 | 983 Million USD | 1.03% |
| 1998 Q4 | 796 Million USD | -19.02% |
| 1997 FY | 3.34 Billion USD | 8.64% |
| 1997 Q2 | 697 Million USD | -25.05% |
| 1997 Q3 | 885 Million USD | 26.97% |
| 1997 Q4 | 835 Million USD | -5.65% |
| 1997 Q1 | 930 Million USD | 16.1% |
| 1996 Q1 | 809 Million USD | 20.07% |
| 1996 Q3 | 835 Million USD | 45.47% |
| 1996 Q4 | 801 Million USD | -4.07% |
| 1996 FY | 3.08 Billion USD | 20.3% |
| 1996 Q2 | 574 Million USD | -29.05% |
| 1995 Q3 | 691.4 Million USD | 28.9% |
| 1995 Q1 | 630.9 Million USD | 25.45% |
| 1995 FY | 2.56 Billion USD | 29.79% |
| 1995 Q4 | 673.8 Million USD | -2.55% |
| 1995 Q2 | 536.4 Million USD | -14.98% |
| 1994 Q4 | 502.9 Million USD | -0.79% |
| 1994 FY | 1.97 Billion USD | 115.98% |
| 1994 Q3 | 506.9 Million USD | 27.62% |
| 1994 Q2 | 397.2 Million USD | -29.76% |
| 1994 Q1 | 565.5 Million USD | 263.63% |
| 1993 Q3 | 448.2 Million USD | -19.05% |
| 1993 Q2 | 553.7 Million USD | 13.51% |
| 1993 Q4 | -345.6 Million USD | -177.11% |
| 1993 FY | 913.3 Million USD | -36.73% |
| 1993 Q1 | 487.8 Million USD | 36.56% |
| 1992 FY | 1.44 Billion USD | 15.15% |
| 1992 Q3 | 403 Million USD | 46.87% |
| 1992 Q2 | 274.4 Million USD | -32.88% |
| 1992 Q1 | 408.8 Million USD | 56.75% |
| 1992 Q4 | 357.2 Million USD | -11.36% |
| 1991 Q1 | 372.7 Million USD | 76.97% |
| 1991 Q2 | 246.6 Million USD | -33.83% |
| 1991 Q3 | 373.4 Million USD | 51.42% |
| 1991 Q4 | 260.8 Million USD | -30.16% |
| 1991 FY | 1.25 Billion USD | 18.95% |
| 1990 FY | 1.05 Billion USD | 8.84% |
| 1990 Q4 | 210.6 Million USD | -35.89% |
| 1990 Q3 | 328.5 Million USD | 56.95% |
| 1990 Q2 | 209.3 Million USD | -31.47% |
| 1990 Q1 | 305.4 Million USD | 109.52% |
| 1989 Q1 | 1.43 Billion USD | 147.79% |
| 1989 Q2 | 1.3 Billion USD | -9.3% |
| 1989 FY | 968.2 Million USD | -4.32% |
| 1989 Q4 | -3.2 Billion USD | -323.1% |
| 1989 Q3 | 1.43 Billion USD | 10.42% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbbVie Inc. | 12.75 Billion USD | 73.669% |
| Bristol-Myers Squibb Company | 16.59 Billion USD | 79.763% |
| Bristol-Myers Squibb Company Ce | 16.59 Billion USD | 79.763% |
| Johnson & Johnson | 23.4 Billion USD | 85.651% |
| Eli Lilly and Company | 10.32 Billion USD | 67.469% |
| Merck & Co., Inc. | 2.95 Billion USD | -13.71% |
| Novartis AG | 9.76 Billion USD | 65.616% |
| Organon & Co. | 1.32 Billion USD | -152.746% |